Bausch Health Companies Interest Expense 2011-2025 | BHC

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Bausch Health Companies

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-28 M	-35 M	-373 M	-502 M	-1.43 B	20 M	348 M	-73 M	-295 M	263 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
348 M	-1.43 B	-210 M

Quarterly Interest Expense Bausch Health Companies

2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-20 M	-	-	-60 M	83 M	-23 M	-	-4 M	-	-2 M	-	183 M	-542 M	30 M	-	-18 M	-118 M	-36 M	-	-10 M	-8 M	3 M	-	15 M	-	-11 M	-	325 M	19 M	240 M	-	-1 M	46 M	-25 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
325 M	-542 M	2.87 M

Interest Expense of other stocks in the Drug manufacturers industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Alimera Sciences ALIM	10.2 M	-	-	$ 142 M	USA
Assertio Holdings ASRT	2.78 M	$ 0.76	-0.88 %	$ 54 M	USA
Aerie Pharmaceuticals AERI	-27.9 M	-	-	$ 754 M	USA
AcelRx Pharmaceuticals ACRX	1.12 M	-	7.5 %	$ 6.35 M	USA
Canopy Growth Corporation CGC	74.6 M	$ 1.69	-2.88 %	$ 182 M	Canada
Adamis Pharmaceuticals Corporation ADMP	4.92 K	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	1.42 M	-	10.11 %	$ 58.2 M	USA
Catalent CTLT	-4 M	-	-	$ 11.5 B	USA
HEXO Corp. HEXO	20.1 M	-	2.45 %	$ 38.1 M	Canada
DURECT Corporation DRRX	2.24 M	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	4.04 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	350 M	-	-	$ 28.9 M	Irlanda
Emergent BioSolutions EBS	87.9 M	$ 11.73	2.71 %	$ 601 M	USA
Evoke Pharma EVOK	500 K	$ 10.96	0.09 %	$ 36.6 M	USA
Athenex ATNX	25.8 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	13 M	$ 21.44	0.37 %	$ 2.04 B	France
Evolus EOLS	127 K	$ 7.21	2.34 %	$ 447 M	USA
Harrow Health HROW	21.3 M	$ 46.92	-0.31 %	$ 1.53 B	USA
China Pharma Holdings CPHI	27.4 K	$ 1.45	-6.69 %	$ 25.3 M	China
Lannett Company LCI	58 M	-	1.15 %	$ 7.11 M	USA
Cumberland Pharmaceuticals CPIX	606 K	$ 2.72	7.58 %	$ 38.2 M	USA
Organogenesis Holdings ORGO	20 K	$ 4.92	2.07 %	$ 648 M	USA
Pacira BioSciences PCRX	-373 K	$ 26.69	1.52 %	$ 1.23 B	USA
Neoleukin Therapeutics NLTX	12 K	-	-	$ 193 M	Canada
Rockwell Medical RMTI	2.3 M	$ 0.92	-0.69 %	$ 21.5 M	USA
Solid Biosciences SLDB	652 K	$ 5.86	-0.26 %	$ 239 M	USA
PetIQ PETQ	38.3 M	-	1.64 %	$ 400 M	USA
Sonoma Pharmaceuticals SNOA	-10 K	$ 3.63	0.97 %	$ 4.5 M	USA
Relmada Therapeutics RLMD	5.15 M	$ 4.18	2.83 %	$ 126 M	USA
Jupiter Wellness JUPW	-5.37 M	-	-	$ 33.6 M	USA
Perrigo Company plc PRGO	900 K	$ 13.34	1.56 %	$ 1.83 B	USA
ProPhase Labs PRPH	764 K	$ 0.12	2.0 %	$ 1.9 M	USA
Radius Health RDUS	18.3 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	9.96 M	-	-4.76 %	$ 65.3 M	USA
Sundial Growers SNDL	81 K	$ 2.07	-6.28 %	$ 3.37 M	Canada
Veru VERU	862 K	$ 2.53	4.47 %	$ 341 M	USA
OptiNose OPTN	19.5 M	-	-	$ 1.08 B	USA
cbdMD YCBD	-29.5 K	$ 1.35	10.66 %	$ 5.82 M	USA
SCYNEXIS SCYX	3.13 M	$ 0.64	-1.58 %	$ 30.6 M	USA
Tricida TCDA	17.6 M	-	-	$ 3.25 M	USA
Tilray TLRY	46.6 M	$ 11.17	-8.08 %	$ 6.9 B	Canada
TherapeuticsMD TXMD	300 K	$ 1.83	4.82 %	$ 19.1 M	USA
Zomedica Corp. ZOM	175 K	-	-0.21 %	$ 98 M	USA
Viatris VTRS	592 M	$ 11.76	0.94 %	$ 14.3 B	USA